Medication Use for the Risk Reduction of Primary Breast Cancer in Women
Author:
Affiliation:
1. Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland
2. School of Public Health, Oregon Health & Science University, Portland
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/article-pdf/322/9/868/17833814/jama_nelson_2019_us_190007.pdf
Reference115 articles.
1. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.;Moyer;Ann Intern Med,2013
2. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.;Nelson;Ann Intern Med,2013
3. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial;Cuzick;Lancet,2014
4. The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial.;Richardson;Curr Oncol,2007
5. Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.;van de Velde;Lancet,2011
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A selective review of inhibitors of protein kinase C gamma: a neuroplasticity-related common pathway for psychiatric illness;Frontiers in Drug Delivery;2024-09-13
2. Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative;Breast Cancer Research and Treatment;2024-09-10
3. Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models;The American Journal of Pathology;2024-07
4. Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis;Cancers;2024-06-25
5. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets;Signal Transduction and Targeted Therapy;2024-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3